ALAMEDA, Calif. (AP) _ OncoCyte Corp. (OCX) on Monday reported a loss of $3.1 million in its fourth quarter.
On a per-share basis, the Alameda, California-based company said it had a loss of 11 cents.
For the year, the company reported a loss of $11.2 million, or 42 cents per share.
OncoCyte shares have decreased 20 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $5.65, a climb of 69 percent in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on OCX at https://www.zacks.com/ap/OCX
Keywords: OncoCyte, Earnings Report